Nabumetone Tablet, Film Coated
Product Images NDC 51655-396

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 51655-396). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 396 25 Master Bottle Label Approval Rev A 07 20)

Label (51655 396 25 Master Bottle Label Approval   Rev A 07 20)
NDC 51655-396-25 is a prescription drug. It contains 500mg Nabumetone in 60 Tablets. The drug is labeled as USP. No further information is available.*
FDA Label Image

Structure (Nabumetone 1)

FDA Label Image

6mna (Nabumetone 2)

FDA Label Image

Figure (Nabumetone 3)

Figure (Nabumetone 3)
This is a graph showing the plasma concentrations of Nabumetone Active Metabolite at steady state following a once-daily dosing of Nabumetone 1000mg and 2000mg. The x-axis indicates the time in hours while the y-axis shows the concentration in mg/mL. There were 31 participants in the 1000mg group and 12 in the 2000mg group.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.